International. Basf celebrated on October 23 the opening of a new state-of-the-art production plant for biocatalyzed acrylamide at its headquarters in Nanjing Chemical Industrial Park, Nanjing, China.
With this investment in its wholly-owned BioACM plant in Nanjing, BASF is strengthening its production system for reliable, high-quality supply of polyacrylamide to customers in Asia Pacific, especially in China. The plant has a capacity of more than 50,000 tons of biocatalyzed acrylamide per year.
Acrylamide is used in the production of water-soluble flocculation adjuvants that make wastewater treatment and papermaking more efficient, as well as mineral processing and improved oil recovery, and also require fewer resources. This new plant strengthens BASF's position in the region and will help expand cost-competitive supply to meet the growing demand from these water-intensive industries.
BASF has been producing biocatalyzed acrylamide in Suffolk, USA, since 2014 and began operations at its European BioACM plant in Bradford, England, in 2016. With this new start-up in China, BASF now has three state-of-the-art facilities located in key markets around the world.
